Catherine T. Doherty Quest Diagnostics Inc (DGX) insider trading activity

Catherine T. Doherty is EVP, Regional Businesses of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 68,068 shares of DGX, which is worth approximately $9.33 Million. The most recent transaction as insider was on Feb 24, 2023, when has been sold 1,690 shares (Common Stock) at a price of $141.42 per share, resulting in proceeds of $238,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.1K

0.5% 3M change

0.5% 12M change

Total Value Held $9.33 Million

Catherine T. Doherty Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 24 2023	SELL Open market or private sale	$238,999 $141.42 p/Share	1,690 Reduced 2.39%	68,919 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$142,241 $147.86 p/Share	962 Reduced 1.42%	66,771 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	3,838 Added 5.16%	70,609 Common Stock
Nov 28 2022	SELL Open market or private sale	$6,079,692 $149.14 p/Share	40,765 Reduced 37.57%	67,733 Common Stock
Nov 28 2022	BUY Exercise of conversion of derivative security	$3,531,471 $86.63 p/Share	40,765 Added 27.31%	108,498 Common Stock
Mar 08 2022	SELL Open market or private sale	$950,797 $135.21 p/Share	7,032 Reduced 9.41%	67,733 Common Stock
Mar 07 2022	SELL Payment of exercise price or tax liability	$827,372 $130.09 p/Share	6,360 Reduced 7.84%	74,765 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	$1,742,165 $130.09 p/Share	13,392 Added 14.17%	81,125 Common Stock
Feb 24 2022	SELL Open market or private sale	$347,215 $126.26 p/Share	2,750 Reduced 4.1%	64,405 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	3,328 Added 4.68%	67,733 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$204,872 $130.16 p/Share	1,574 Reduced 2.29%	67,155 Common Stock
Nov 29 2021	SELL Open market or private sale	$5,847,368 $155.66 p/Share	37,565 Reduced 35.34%	68,729 Common Stock
Nov 29 2021	BUY Exercise of conversion of derivative security	$3,598,727 $95.8 p/Share	37,565 Added 26.11%	106,294 Common Stock
May 07 2021	SELL Open market or private sale	$1,194,699 $139.96 p/Share	8,536 Reduced 11.05%	68,729 Common Stock
Mar 09 2021	SELL Payment of exercise price or tax liability	$584,718 $115.42 p/Share	5,066 Reduced 6.15%	77,265 Common Stock
Mar 09 2021	BUY Grant, award, or other acquisition	$1,304,131 $115.42 p/Share	11,299 Added 12.07%	82,331 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$63,504 $121.19 p/Share	524 Reduced 0.73%	71,032 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$96,435 $121.15 p/Share	796 Reduced 1.1%	71,556 Common Stock
Feb 17 2021	BUY Grant, award, or other acquisition	-	3,941 Added 5.17%	72,352 Common Stock

CTD

Catherine T. Doherty

EVP, Regional Businesses

Secaucus, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Value

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX

Account